ArticleTherapeutic advances in hematology2021

Interferon-α may help prevent molecular relapse of chronic myeloid leukemia after the discontinuation of tyrosine kinase inhibitors.

Kong Jun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.